These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33908356)
1. "No" to placebo-controlled trials of Covid-19 vaccines. Ahmad A; Dhrolia MF Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356 [TBL] [Abstract][Full Text] [Related]
2. Problematic Covid-19 vaccine trials in times of vaccine nationalism. Ravinetto R Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359 [TBL] [Abstract][Full Text] [Related]
3. Placebo in new Covid-19 vaccine trials: data quality prioritised over participants' rights. Srinivasan S Indian J Med Ethics; 2021; VI(2):1-6. PubMed ID: 33908351 [TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled trials of Covid-19 vaccines - Are they still ethical? Ortiz-Millán G Indian J Med Ethics; 2021; VI(2):1-8. PubMed ID: 33908358 [TBL] [Abstract][Full Text] [Related]
5. Trials for second generation Covid-19 vaccines: Revisiting the debate over placebo use in developing country clinical trials. Lurie P Indian J Med Ethics; 2021; VI(2):1-10. PubMed ID: 33908352 [TBL] [Abstract][Full Text] [Related]
6. Placebo control in Covid-19 trials: A missed opportunity for international guidance. Wiesing U; Ehni HJ Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908353 [TBL] [Abstract][Full Text] [Related]
7. Testing vaccines in the time of Covid: The changing landscape. Cash RA Indian J Med Ethics; 2021; VI(2):1-4. PubMed ID: 33908357 [TBL] [Abstract][Full Text] [Related]
8. The continued use of placebo arms in COVID-19 vaccine trials does not adequately protect the well-being of participants. Haire B Indian J Med Ethics; 2021; VI(2):1-10. PubMed ID: 33908354 [TBL] [Abstract][Full Text] [Related]
9. Covid-19, the WHO, and the apparent collapse of traditional medical research ethics. Tangwa GB Indian J Med Ethics; 2021; VI(2):1-12. PubMed ID: 33908349 [TBL] [Abstract][Full Text] [Related]
10. Ethical limits to placebo use and access to Covid-19 vaccines as a human right. Greco DB Indian J Med Ethics; 2021; VI(2):1-14. PubMed ID: 33908350 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 vaccine trials: The use of active controls and non-inferiority studies. Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811 [TBL] [Abstract][Full Text] [Related]
12. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials. Rid A; Lipsitch M; Miller FG JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080 [No Abstract] [Full Text] [Related]
13. COVID-19 vaccine trials: The potential for "hybrid" analyses. Fleming TR; Nason M; Krause PR; Longini IM; Henao-Restrepo AM Clin Trials; 2021 Aug; 18(4):391-397. PubMed ID: 34041932 [TBL] [Abstract][Full Text] [Related]
14. Covid-19 vaccine trials and ethics: Protection delayed is protection denied. John TJ; Dharmapalan D Indian J Med Ethics; 2021; VI(1):1-5. PubMed ID: 34080997 [TBL] [Abstract][Full Text] [Related]
15. Restrictions on the use of placebo in new COVID-19 vaccine trials. Bonati M Eur J Clin Pharmacol; 2022 Jan; 78(1):147-148. PubMed ID: 34462794 [No Abstract] [Full Text] [Related]